Related Experiment Video

Updated: Nov 19, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.6K

Tiragolumab Impresses in Multiple Trials

    Cancer Discovery
    |June 25, 2020
    PubMed

    Insights

    Tiragolumab, a TIGIT inhibitor, shows promise in treating solid cancers, particularly non-small cell lung cancer. Clinical trials indicate effectiveness when used alone or with atezolizumab, a PD-L1 inhibitor.

    Area of Science:

    • Immunotherapy
    • Oncology
    • Cancer Research

    Background:

    • Investigating the efficacy of tiragolumab, a TIGIT inhibitor, as a potential cancer therapeutic.
    • Evaluating tiragolumab's activity both as a monotherapy and in combination with atezolizumab, a PD-L1 inhibitor.

    Discussion:

    • Tiragolumab demonstrates potential in treating various solid tumors.
    • The combination of tiragolumab and atezolizumab warrants further investigation for enhanced anti-cancer effects.

    Key Insights:

    • Phase I and II trials yielded statistically significant results for tiragolumab across multiple solid malignancies.
    • Non-small cell lung cancer emerged as a particularly responsive tumor type.

    Outlook:

    • Further clinical trials are needed to confirm the therapeutic potential of tiragolumab in solid cancers.
    • Exploring optimal combination strategies involving TIGIT and PD-L1 inhibition for improved patient outcomes.

    More Related Videos

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

    Published on: April 16, 2019

    18.7K
    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    27.7K

    Related Concept Videos

    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    864
    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
    4.3K
    Clinical Trials01:16

    Clinical Trials

    Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
    There are four phases in a clinical trial. A phase one...
    10.0K